Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cytotoxic Edema: Pathophysiology

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cellular Injury IV: Necrosis

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

From overuse to self-control: impact of a psychosocial skills program in preventing internet addiction among Tunisian adolescents.

European child & adolescent psychiatry·2026

Same author

Pharmacogenomics of treatment toxicities in pediatric B-Cell ALL: toward safer precision therapy.

Frontiers in pharmacology·2026

Same author

Therapeutic outcomes of acute promyelocytic leukemia in children.

Leukemia research reports·2026

Same author

[Posterior Reversible Encephalopathy Syndrome in children/ adolescents with hematologic malignancies: Case reports].

La Tunisie medicale·2026

Same author

Patterns of early exposure to screens by children with ASD.

Discover mental health·2025

Same author

Avapritinib and corticosteroids in advanced systemic mastocytosis with tumoral CMML and associated thrombocytopenia.

Oxford medical case reports·2025

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis

Published on: November 14, 2025

[Tumor lysis syndrome].

Ramzi Jeddi¹, Yosr Ben Abdennebi, Bassam Allani

¹Service d'hématologie clinique, Hopital Aziza othmana, Tunis.

La Tunisie Medicale

|August 2, 2007

Summary

Tumor lysis syndrome is a life-threatening oncologic emergency caused by rapid cancer cell death, leading to metabolic issues and potential organ damage. Immediate medical intervention, including hydration and medications like allopurinol, is crucial for managing this condition.

More Related Videos

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Published on: June 9, 2016

Related Experiment Videos

Last Updated: Jul 13, 2026

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis

Published on: November 14, 2025

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Published on: June 9, 2016

Area of Science:

Oncology
Nephrology
Internal Medicine

Context:

Tumor lysis syndrome (TLS) is a critical oncologic emergency.
It arises from the rapid breakdown of malignant cells, either spontaneously or due to cancer treatment.
TLS can lead to severe metabolic derangements and organ dysfunction.

Purpose:

To summarize the pathophysiology, clinical presentation, and management of tumor lysis syndrome.
To highlight the importance of early recognition and intervention in at-risk patients.
To provide an overview of current therapeutic strategies for TLS.

Summary:

TLS is characterized by metabolic abnormalities including hyperkalemia, hyperuricemia, and hyperphosphatemia, with secondary hypocalcemia.
These imbalances pose significant risks for acute kidney injury and cardiac arrhythmias.
High-risk patients often have large tumor burdens and cancers highly sensitive to chemotherapy, such as leukemia and lymphoma.

Impact:

Effective management of TLS is vital to prevent severe complications and improve patient outcomes.
Understanding TLS guides prompt medical intervention, potentially saving lives.
This overview reinforces the standard of care, emphasizing hydration and specific pharmacotherapies.